CAPORALI, ROBERTO FELICE
CAPORALI, ROBERTO FELICE
Dipartimento di Scienze Cliniche e di Comunità
Correspondence on 'Anti-inflammatory therapy for COVID-19 infection: the case for colchicine'
2023 C. Perricone, E. Bartoloni, G. Cafaro, R. Caporali, R. Gerli
Correspondence on 'Non-surgical and surgical treatments for rotator cuff disease: a pragmatic randomised clinical trial with 2-year follow-up after initial rehabilitation'
2023 P. Randelli, L.A. Coletto, A. Menon, R. Caporali
Case report: Prader-Willi syndrome and inflammatory arthritis-An important consideration
2023 L. Marelli, T. Dallos, E. Miserocchi, P. Nucci, B. Tombolini, O. De Lucia, M. Gattinara, R. Caporali, A. Marino
Owning Pets Reduces the Perception of Disease Activity in Patients With Rheumatoid Arthritis
2023 C. Posio, I. Suardi, R. Caporali, F. Ingegnoli
Long-term use of burosumab for the treatment of tumor-induced osteomalacia
2023 C. Crotti, F. Zucchi, C. Alfieri, R. Caporali, M. Varenna
Disease activity and disease-related factors are drivers of patient global assessment in rheumatoid arthritis: a real-life cross-sectional study
2023 I. Suardi, C. Posio, E. Luconi, P. Boracchi, R. Caporali, F. Ingegnoli
Olive Oil and Nuts in Rheumatoid Arthritis Disease Activity
2023 R. De Vito, F. Fiori, M. Ferraroni, S. Cavalli, R. Caporali, F. Ingegnoli, M. Parpinel, V. Edefonti
Expert consensus on the treatment of patients with adult-onset still's disease with the goal of achieving an early and long-term remission
2023 R. Giacomelli, R. Caporali, F. Ciccia, S. Colafrancesco, L. Dagna, M. Govoni, F. Iannone, P. Leccese, C. Montecucco, G. Pappagallo, G. Pistone, R. Priori, P. Ruscitti, P. Sfriso, L. Cantarini, N. Belfiore, C. Bernardi, M. Gabini, S. Bettio, A. Brucato, G. Italiano, F.P. Cantatore, D. Iacono, I. Pantano, E. Tirri, F. Ursini, A.L. Monaco, F. Caso, L. Quartuccio, M.S. Chimenti, A. Gattamelata, E. Gremese, M. Paroli, A. Picchianti-Diamanti, G.D. Sebastiani, E. Favalli, A. Sulli, M. Frassi, P. Faggioli, R. Foti, C. Campochiaro, G. Cavalli, A. Tomelleri, M. Manara, L. De Stefano, R. De Angelis, S. Parisi, G. Lopalco, M. Piga, D. Marotto, M. Colaci, A. Padula, G. Guggino, G. Emmi, C. Baldini, J. Sota, A. Vitale, A. Berti, E. Bartoloni, C. Grava, S. Bindoli, R. Vitetta
Tight control in patients with rheumatoid arthritis treated with targeted therapies across the COVID-19 pandemic era
2023 A.F. Luppino, G. Cincinelli, A. Orenti, P. Boracchi, E.G. Favalli, R. Caporali, F. Ingegnoli
Beyond Systemic Lupus Erythematosus and Anti-Phospholipid Syndrome: The Relevance of Complement From Pathogenesis to Pregnancy Outcome in Other Systemic Rheumatologic Diseases
2022 S. Cavalli, P.A. Lonati, M. Gerosa, R. Caporali, R. Cimaz, C.B. Chighizola
Is adipose-tissue (or its fraction) grafting really effective in the treatment of scleroderma hand?
2022 N. Del Papa, C. Vitali, A. Minniti, R. Caporali
Caffeine and rheumatoid arthritis: A complicated relationship
2022 F. Ingegnoli, S. Cavalli, L. Giudice, R. Caporali
Synovial Fluid-Derived Extracellular Vesicles of Patients with Arthritides Contribute to Hippocampal Synaptic Dysfunctions and Increase with Mood Disorders Severity in Humans
2022 C. Cambria, F. Ingegnoli, E. Borzi, L. Cantone, L.A. Coletto, A.S. Rizzuto, O. De Lucia, S. Briguglio, M. Ruscica, R. Caporali, V. Bollati, M. Buoli, F. Antonucci
Retention of subcutaneous abatacept for the treatment of rheumatoid arthritis: real-world results from the ASCORE study: an international 2-year observational study
2022 R. Alten, X. Mariette, R. Flipo, R. Caporali, M.H. Buch, Y. Patel, S. Marsal, R. Sanmartí, M.T. Nurmohamed, H. Griffiths, P. Peichl, B. Bannert, M. Chartier, S.E. Connolly, K. Lozenski, C. Rauch
Myocardial involvement in anti-phospholipid syndrome: Beyond acute myocardial infarction
2022 L. Coletto, M. Gerosa, M. Valentini, R. Cimaz, R. Caporali, P. Meroni, C. Chighizola
Hyaluronic Acid Therapy in Hip OA Does Not Perform Equally in Osteoarthritis Secondary to Juvenile Idiopathic Arthritis When Compared to Primary Osteoarthritis: A 2-Year Preliminary Evaluation
2022 O. DE LUCIA, A.F. Luppino, F. Pregnolato, A. Murgo, I. Pontikaki, M. Gattinara, T. Ubiali, R. Cimaz, R.F. Caporali
Immunosuppressant Treatment in Rheumatic Musculoskeletal Diseases Does Not Inhibit Elicitation of Humoral Response to SARS-CoV-2 Infection and Preserves Effector Immune Cell Populations
2022 A. Favalli, E.G. Favalli, A. Gobbini, E. Zagato, M. Bombaci, G. Maioli, E. Pesce, L. Donnici, P. Gruarin, M. Biggioggero, S. Curti, L. Manganaro, E. Marchisio, V. Bevilacqua, M. Martinovic, T. Fabbris, M.L. Sarnicola, M. Crosti, L. Marongiu, F. Granucci, S. Notarbartolo, A. Bandera, A. Gori, R. De Francesco, S. Abrignani, R. Caporali, R. Grifantini
Subcutaneously-Administered Infliximab in the Management of Rheumatoid Arthritis: A Short Narrative Review of Current Clinical Evidence
2022 F. Iannone, F. Conti, A. Cauli, A. Farina, R. Caporali
Lessons learned from the preclinical discovery and development of sarilumab for the treatment of rheumatoid arthritis
2022 G. Maioli, R.F. Caporali, E.G. Favalli
Clinical and peculiar immunological manifestations of SARS-CoV-2 infection in systemic lupus erythematosus patients
2022 T. Schioppo, L.M. Argolini, S. Sciascia, F. Pregnolato, F. Tamborini, P. Miraglia, D. Roccatello, R.A. Sinico, R. Caporali, G. Moroni, M. Gerosa